American Journal of Cardiology
Volume 104, Issue 4 , Pages 559-564, 15 August 2009

Relation of N-Terminal Pro-B-Type Natriuretic Peptide to Symptoms, Severity, and Left Ventricular Remodeling in Patients With Organic Mitral Regurgitation

  • Mihael Potocki, MD

      Affiliations

    • Department of Internal Medicine, University Hospital, Basel, Switzerland
    • Department of Cardiology, Herzzentrum Bad Krozingen, Bad Krozingen, Germany
    • Corresponding Author InformationCorresponding author: Tel: 41-612652525; fax: 41-612655353
  • ,
  • Johannes Mair, MD

      Affiliations

    • Department of Cardiology, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • Michael Weber, MD

      Affiliations

    • Department of Cardiology, Kerckhoff Klinik, Bad Nauheim, Germany
  • ,
  • Christian Hamm, MD

      Affiliations

    • Department of Cardiology, University Hospital, Basel, Switzerland
  • ,
  • Thilo Burkard, MD

      Affiliations

    • Department of Cardiology, University Hospital, Basel, Switzerland
  • ,
  • Renate Hiemetzberger, MD

      Affiliations

    • Department of Cardiology, Innsbruck Medical University, Innsbruck, Austria
  • ,
  • Klaus Peters, MD

      Affiliations

    • Department of Cardiology, Herzzentrum Bad Krozingen, Bad Krozingen, Germany
  • ,
  • Nikolaus Jander, MD

      Affiliations

    • Department of Cardiology, Herzzentrum Bad Krozingen, Bad Krozingen, Germany
  • ,
  • Thomas A. Cron, MD

      Affiliations

    • Basel, Switzerland
  • ,
  • Niklaus Hess, MD

      Affiliations

    • Basel, Switzerland
  • ,
  • Andreas Hoffmann, MD

      Affiliations

    • Basel, Switzerland
  • ,
  • Helmut Gekeler, MD

      Affiliations

    • Loerrach, Germany
  • ,
  • Christa Gohlke-Bärwolf, MD

      Affiliations

    • Department of Cardiology, Herzzentrum Bad Krozingen, Bad Krozingen, Germany
  • ,
  • Peter Buser, MD

      Affiliations

    • Department of Cardiology, University Hospital, Basel, Switzerland
  • ,
  • Christian Mueller, MD

      Affiliations

    • Department of Internal Medicine, University Hospital, Basel, Switzerland

Received 1 March 2009; received in revised form 13 April 2009; accepted 13 April 2009. published online 22 June 2009.

Natriuretic peptides reflect cardiac stress and may therefore be useful in the management of patients with valvular heart disease. Data regarding these biomarkers in organic mitral regurgitation (MR) are sparse. In this study, 144 patients with moderate or severe organic MR were prospectively enrolled in an observational, multicenter study to analyze the relation of N-terminal–pro-B-type natriuretic peptide (NT–pro-BNP) to symptoms, severity of MR, and echocardiographic parameters. NT–pro-BNP levels (median 373 pg/ml, interquartile range 150 to 997) were associated with age, gender, creatinine, New York Heart Association (NYHA) functional class, atrial fibrillation, left ventricular (LV) end-systolic dimension, and the LV ejection fraction. Independent predictors of increased NT–pro-BNP levels were NYHA functional class (p = 0.003), atrial fibrillation (p = 0.005) and LV end-systolic dimension (p = 0.029). MR severity and left atrial dimension were not independently associated with NT–pro-BNP levels. NT–pro-BNP levels increased significantly with NYHA class (p <0.001) but not with MR severity (p = 0.144). NT–pro-BNP levels were significantly higher in symptomatic patients than in asymptomatic patients (582 pg/ml [interquartile range 246–1,360] vs 157 pg/ml [interquartile range 64 to 256], p <0.0001). The area under the receiver-operating characteristic curve to predict symptoms for NT–pro-BNP was 0.80 (95% confidence interval 0.71 to 0.88), which was significantly higher than for all echocardiographic variables (p <0.001 for all). In conclusion, NYHA functional class, atrial fibrillation, and LV end-systolic dimension are independent predictors of increased NT–pro-BNP levels in patients with moderate or severe organic MR. Therefore, NT–pro-BNP may be helpful in the clinical evaluation and management of patients with MR, especially when it is doubtful whether symptoms are related to MR or not.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by research grants from the Swiss National Science Foundation, Bern, Switzerland; the Swiss Heart Foundation, Bern, Switzerland; the Department of Internal Medicine, University Hospital, Basel, Switzerland; and Roche Diagnostics, Rotkreuz, Switzerland.

PII: S0002-9149(09)00927-8

doi:10.1016/j.amjcard.2009.04.023

American Journal of Cardiology
Volume 104, Issue 4 , Pages 559-564, 15 August 2009